文献速递流行病学与生物统计临床试验与 GCP

评估自适应组序贯设计样本量重估的条件性能评分

A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation.
PubMed 文献 · Stat Med · 2020-04-06

针对自适应组序贯设计在期中分析后重估样本量时缺乏统一性能评价标准的问题,本文综述了样本量重估规则与性能指标,并提出一种新的条件性能评分,通过蒙特卡洛模拟将其应用于多种标准重估规则。

要点

  • 现有样本量重估规则评价常仅报告把握度和平均样本量,忽略重估样本量变异性与条件把握度分布。
  • 新条件性能评分聚焦特定期中结果下的剩余性能,可与全局性能视角结合使用。
  • 该评分通过蒙特卡洛模拟在多种标准重估规则上展示应用。

核心结论

  • 提出一种新的条件性能评分,用于综合评估自适应组序贯设计中样本量重估规则的性能。

研究设计与样本

  • 方法学文章,综述样本量重估规则与性能指标,并通过蒙特卡洛模拟应用新评分。

主要发现

  • 现有评价常报告把握度和平均样本量,但忽略重估样本量变异性和条件把握度分布。
  • 性能评价可从全局性能(对所有可能期中结果平均)或条件性能(特定期中结果下的剩余性能)两个视角进行。

临床怎么用

  • 在评估自适应组序贯设计的样本量重估规则时,可结合条件性能评分与全局性能指标进行综合评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In standard clinical trial designs, the required sample size is fixed in the planning stage based on initial parameter assumptions. It is intuitive that the correct choice of the sample size is of major importance for an ethical justification of the trial. The required parameter assumptions should be based on previously published results from the literature. In clinical practice, however, historical data often do not exist or show highly variable results. Adaptive group sequential designs allow a sample size recalculation after a planned unblinded interim analysis in order to adjust the sample size during the ongoing trial. So far, there exist no unique standards to assess the performance of sample size recalculation rules. Single performance criteria commonly reported are given by the power and the average sample size; the variability of the recalculated sample size and the conditional power distribution are usually ignored. Therefore, the need for an adequate performance score combining these relevant performance criteria is evident. To judge the performance of an adaptive design, there exist two possible perspectives, which might also be combined: Either the global performance of the design can be addressed, which averages over all possible interim results, or the conditional performance is addressed, which focuses on the remaining performance conditional on a specific interim result. In this work, we give a compact overview of sample size recalculation rules and performance measures. Moreover, we propose a new conditional performance score and apply it to various standard recalculation rules by means of Monte-Carlo simulations.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Herrmann C, Pilz M, Kieser M, et al. A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation. Stat Med. 2020. PMID: 32249968. doi:10.1002/sim.8534

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。